Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs PIRAMAL PHYTOCARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA PIRAMAL PHYTOCARE AUROBINDO PHARMA/
PIRAMAL PHYTOCARE
 
P/E (TTM) x 19.7 -6.0 - View Chart
P/BV x 2.4 - - View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 AUROBINDO PHARMA   PIRAMAL PHYTOCARE
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-24
PIRAMAL PHYTOCARE
Mar-19
AUROBINDO PHARMA/
PIRAMAL PHYTOCARE
5-Yr Chart
Click to enlarge
High Rs1,17751 2,298.8%   
Low Rs51726 1,984.6%   
Sales per share (Unadj.) Rs495.09.7 5,115.1%  
Earnings per share (Unadj.) Rs54.1-3.2 -1,704.5%  
Cash flow per share (Unadj.) Rs80.1-3.2 -2,535.9%  
Dividends per share (Unadj.) Rs4.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs509.3-9.8 -5,177.5%  
Shares outstanding (eoy) m585.9425.96 2,257.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.74.0 42.9%   
Avg P/E ratio x15.7-12.2 -128.6%  
P/CF ratio (eoy) x10.6-12.2 -86.5%  
Price / Book Value ratio x1.7-3.9 -42.4%  
Dividend payout %8.30-   
Avg Mkt Cap Rs m496,2901,003 49,494.5%   
No. of employees `000NANA-   
Total wages/salary Rs m39,22957 69,297.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m290,019251 115,453.3%  
Other income Rs m5,5741 1,051,660.4%   
Total revenues Rs m295,593252 117,424.4%   
Gross profit Rs m56,340-75 -75,179.9%  
Depreciation Rs m15,2170 3,623,000.0%   
Interest Rs m2,8978 38,423.1%   
Profit before tax Rs m43,800-82 -53,174.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,1100-   
Profit after tax Rs m31,690-82 -38,472.4%  
Gross profit margin %19.4-29.8 -65.1%  
Effective tax rate %27.60-   
Net profit margin %10.9-32.8 -33.3%  
BALANCE SHEET DATA
Current assets Rs m237,71974 322,988.0%   
Current liabilities Rs m121,991333 36,606.5%   
Net working cap to sales %39.9-103.4 -38.6%  
Current ratio x1.90.2 882.3%  
Inventory Days Days174 376.6%  
Debtors Days Days6193 64.9%  
Net fixed assets Rs m196,5326 3,382,657.5%   
Share capital Rs m586260 225.7%   
"Free" reserves Rs m297,842-515 -57,836.8%   
Net worth Rs m298,428-255 -116,861.0%   
Long term debt Rs m21,3490-   
Total assets Rs m438,58979 552,309.2%  
Interest coverage x16.1-9.9 -162.4%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.73.2 20.9%   
Return on assets %7.9-94.2 -8.4%  
Return on equity %10.632.3 32.9%  
Return on capital %14.629.3 49.8%  
Exports to sales %32.90.8 3,882.5%   
Imports to sales %11.50-   
Exports (fob) Rs m95,3422 4,476,150.2%   
Imports (cif) Rs m33,308NA-   
Fx inflow Rs m98,2902 4,614,554.0%   
Fx outflow Rs m38,1380 29,337,076.9%   
Net fx Rs m60,1522 3,007,590.0%   
CASH FLOW
From Operations Rs m24,345-137 -17,770.2%  
From Investments Rs m-42,560NA-  
From Financial Activity Rs m8,004128 6,261.1%  
Net Cashflow Rs m-10,068-9 109,917.0%  

Share Holding

Indian Promoters % 48.8 56.1 86.9%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 41.7 4.0 1,040.4%  
FIIs % 16.6 0.6 2,592.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 43.9 109.7%  
Shareholders   248,488 47,837 519.4%  
Pledged promoter(s) holding % 21.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on Aurobindo Pharma vs PIRAMAL LIFE SCIEN.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs PIRAMAL LIFE SCIEN. Share Price Performance

Period Aurobindo Pharma PIRAMAL LIFE SCIEN. S&P BSE HEALTHCARE
1-Day -2.22% -4.04% 0.11%
1-Month -16.36% -4.25% -3.22%
1-Year 18.84% -22.24% 42.65%
3-Year CAGR 24.80% -37.14% 19.86%
5-Year CAGR 23.22% -11.25% 25.90%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the PIRAMAL LIFE SCIEN. share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of PIRAMAL LIFE SCIEN. the stake stands at 56.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of PIRAMAL LIFE SCIEN..

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 4.5 per share. This amounted to a Dividend Payout ratio of 8.3%.

PIRAMAL LIFE SCIEN. paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of PIRAMAL LIFE SCIEN..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.